Skip to Main Content
Table 2.

Distribution of GM and KM phenotypes in relation to IgG and IgM antibody levels to MUC1 in patients with gastric cancer

PhenotypesNo. subjectsAntibody levels (median, interquartile range)
MUC1 IgG (RU)MUC1 IgM (RU)
GM 3 23 5,13 68 65.5* (41.5–121.5) 32.5 (20.2–49.0) 
GM 1,3,17 23 5,13,21 32 84.5 (60.0–134.5) 35.5 (23.0–43.0) 
GM 3 5,13 16 143.0 (51.0–283.0) 31.0 (19.5–41.5) 
GM 1,3,17 5,13,21 14 71.5 (45.0–171.0) 45.5 (16.0–65.0) 
GM 1,2,3,17 23 5,13,21 10 114.5 (101.0–149.0) 24.0 (20.0–41.0) 
GM 1,2,3,17 5,13,21 10 158.0 (49.0–366.0) 37.5 (28.0–47.0) 
Other GM 19 69.0 (49.0–172.0) 27.0 (15.0–42.0) 
KM 1 NA NA 
KM 1,3 20 88.0 (40.0–166.5) 35.0 (18.5–52.5) 
KM 3 149 82.0 (48.0–145.0) 33.0 (20.0–46.0) 
PhenotypesNo. subjectsAntibody levels (median, interquartile range)
MUC1 IgG (RU)MUC1 IgM (RU)
GM 3 23 5,13 68 65.5* (41.5–121.5) 32.5 (20.2–49.0) 
GM 1,3,17 23 5,13,21 32 84.5 (60.0–134.5) 35.5 (23.0–43.0) 
GM 3 5,13 16 143.0 (51.0–283.0) 31.0 (19.5–41.5) 
GM 1,3,17 5,13,21 14 71.5 (45.0–171.0) 45.5 (16.0–65.0) 
GM 1,2,3,17 23 5,13,21 10 114.5 (101.0–149.0) 24.0 (20.0–41.0) 
GM 1,2,3,17 5,13,21 10 158.0 (49.0–366.0) 37.5 (28.0–47.0) 
Other GM 19 69.0 (49.0–172.0) 27.0 (15.0–42.0) 
KM 1 NA NA 
KM 1,3 20 88.0 (40.0–166.5) 35.0 (18.5–52.5) 
KM 3 149 82.0 (48.0–145.0) 33.0 (20.0–46.0) 

Abbreviation: NA, not applicable.

*

Significantly lower (P = 0.0058, obtained by analysis of covariance log10 transformed data) compared with the rest of the GM phenotypes.

Close Modal

or Create an Account

Close Modal
Close Modal